Multiplikator Forward P/S: Cutera (CUTR)
Cutera, Inc. (CUTR) has stabilized liquidity through strict resource austerity. Growth is driven by the innovative AviClear device and cost reductions. The expected P/S ratio reflects market sentiment, where the level of 0.00 is the current value. An aggressive corporate culture and high bonuses retain top engineers, confirming the development potential shown on this chart.
Ringkesan rincian data analitis Cutera Inc (CUTR)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Cutera, Inc.|CUTR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Cutera, Inc.|CUTR - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Cutera Inc|CUTR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cutera|Rasio cepet cutera.com
- rincian asil keuangan lan kelipatan valuasi:
CUTR - Penghasilan resik perusahaan|Bathi sing dikarepake Cutera, Inc.|CUTR - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Cutera, Inc|CUTR - Pangali PEG|Pangali EV/EBITDA Cutera Inc|CUTR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Cutera|CUTR - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cutera.com|CUTR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Cutera, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:CUTR (Cutera)
The assessment of Cutera, Inc. (CUTR) operational resilience is based on comparing market value with expected sales volume, which determines the premium paid for future growth. This forward P/S ratio for Cutera, Inc. (CUTR) measures the ratio of market capitalization to planned revenue from the sale of aesthetic equipment and consumables, reflecting market expectations for the expansion of Cutera, Inc. (CUTR) in the dermatology segment through the price action on the chart.
Karo sapa Cutera, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Beyond Air|Multiplikator forward rega marang pendapatan PFSA|Multiplikator Forward P/S STRATA Skin|Multiplikator forward rega marang pendapatan GCTK (GlucoTrack)|Rasio rega marang pendapatan sing dikarepake NAOV|Multiplikator Forward P/S VERO (Venus Concept Inc.)|nuwellis.com (NUWE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|AEMD - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan ASXC (Asensus Surgical, Inc.)|AVGR: Multiplikator Forward P/S|Biosig Technologies (BSGM) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Multiplikator Forward P/S NVRO|Rasio kapitalisasi marang dodolan sing dikarepake reshapelifesciences.com|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
